News

Press Releases
Kane Biotech successfully completes wound gel for the United States Army

Highlights:

Wound gel reduced over 95% of biofilm-embedded bacteria versus approximately 50% reduction by industry leading product Superior performance is due to synergy between DispersinB® and antimicrobial peptide

WINNIPEG, Manitoba (April 17, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology…

> Read More

Press Releases
Kane Biotech Provides Corporate Update

Highlights:

FDA Response received on DispersinB® topical wound care and regulatory strategy formulated Prototype formulation completed for US Army Health Canada approval for KBI Hard Surface Disinfectant received for household use and application for expanded label submitted

WINNIPEG, Manitoba (February…

> Read More

Press Releases
Kane Biotech Renews Investor Relations Agreement With Pure Advertising and Marketing for 2012

WINNIPEG, Manitoba (January 17, 2012) – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, is pleased to announce it has renewed the service agreement with Pure Advertising…

> Read More

In the Media
Kane Biotech invention helps grow bone cells (PDF)
Winnipeg Free Press
In the Media
Superbug surfaces in Canada (PDF)
The Globe and Mail.com